A Clinical Update for the Treatment of Multiple Myeloma with Reduced Bone Complications
WebcastFaculty
OVERVIEW
A Clinical Update for the Treatment of Multiple Myeloma with Reduced Bone Complications is organized by Academic CME and will be held during Sep 14, 2017 - Sep 13, 2018.
The target audience for this medical event is Hematologists/Oncologists, primary care physicians, nurse practitioners, and other healthcare professionals responsible for the treatment of Multiple Myeloma. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
This CME/CNE activity will include clinical updates for the treatment of Multiple Myeloma with reduced bone complications. Expert faculty will review the science of multiple myeloma, including disease course, patient assessment and comorbidities. The current head to head trial data for emerging therapeutics for the treatment of relapsed/refractory multiple myeloma will be analyzed. The faculty will guide clinicians on how to incorporate optimal treatment strategies into patient-specific plans to improve the overall survival in patients with multiple myeloma with reduced bone complications. Upon completing this activity, clinicians will gain knowledge on the most up-to-date care for this cohort of patients.
Conference Objectives are :
• Identify the science of multiple myeloma, including disease course, patient assessment and comorbidities.
• Analyze the current head to head trial data for emerging therapeutics for the treatment of relapsed/refractory multiple myeloma.
• Incorporate optimal treatment strategies into patient-specific plans to improve the overall survival in patients with multiple myeloma with reduced bone complications.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Hematologists/Oncologists, primary care physicians, nurse practitioners, and other healthcare professionals responsible for the treatment of Multiple Myeloma. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
This CME/CNE activity will include clinical updates for the treatment of Multiple Myeloma with reduced bone complications. Expert faculty will review the science of multiple myeloma, including disease course, patient assessment and comorbidities. The current head to head trial data for emerging therapeutics for the treatment of relapsed/refractory multiple myeloma will be analyzed. The faculty will guide clinicians on how to incorporate optimal treatment strategies into patient-specific plans to improve the overall survival in patients with multiple myeloma with reduced bone complications. Upon completing this activity, clinicians will gain knowledge on the most up-to-date care for this cohort of patients.
Conference Objectives are :
• Identify the science of multiple myeloma, including disease course, patient assessment and comorbidities.
• Analyze the current head to head trial data for emerging therapeutics for the treatment of relapsed/refractory multiple myeloma.
• Incorporate optimal treatment strategies into patient-specific plans to improve the overall survival in patients with multiple myeloma with reduced bone complications.
Additional details will be posted as soon as they are available.
SPECIALITIES
OncologyHematology Blood and Marrow Transplant
Quick Links